M/22/049 – Uniphar/LXV Remedies (Sam McCauley)
The proposed acquisition by Uniphar plc, through its wholly-owned subsidiary Trennamally Limited, of LXV Remedies Holdings Limited has been cleared by the Competition and Consumer Protection Commission subject to a number of legally binding commitments.
|Notification date||Decision date|
|Monday September 19, 2022||Friday, January 20, 2023|
|Parties Involved||Business activities|
Headquartered in Dublin, Uniphar is an Irish-incorporated public limited company traded on Euronext Dublin and the London Stock Exchange. It is an international diversified healthcare services business, servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three sectors/divisions - commercial & clinical, product access and supply chain & retail.
|LXV Remedies Holdings Limited||
LXV Remedies is the ultimate parent company of Sam McCauley Chemists Limited. Sam McCauley owns and operates a group of 37 retail pharmacies located across Leinster, Munster and Ulster. All of the 37 pharmacies trade under the name McCauley Health & Beauty Pharmacy.
|Economic sector||Media merger|
|Submissions from third parties due by:|
|Phase 1||Phase 2|
|Tuesday, October 4, 2022|
|Current status: Completed|
|Cleared with agreed measures (Phase 1)|
|Authorised Officer Assigned||Contact Details|
Media enquiries: firstname.lastname@example.org